Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth
- PMID: 12620384
- DOI: 10.1016/s0882-4010(02)00197-3
Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth
Abstract
Leg ulcers of venous origin represent a disease affecting 0.1-0.2% of the population. It is known that almost all chronic ulcers are colonized by different bacteria, such as staphylococci, enterococci and Pseudomonas aeruginosa. We here report that P. aeruginosa, expressing the major metalloproteinase elastase, induces degradation of complement C3, various antiproteinases, kininogens, fibroblast proteins, and proteoglycans (PG) in vitro, thus mimicking proteolytic activity previously identified in chronic ulcer fluid in vivo. Elastase-producing P. aeruginosa isolates were shown to significantly degrade human wound fluid as well as human skin proteins ex vivo. Elastase-containing conditioned P. aeruginosa medium and purified elastase inhibited fibroblast cell growth. These effects, in conjunction with the finding that proteinase production was detected in wound fluid ex vivo, suggest that bacterial proteinases play a pathogenic role in chronic ulcers.
Similar articles
-
Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers.Acta Derm Venereol. 2001 Nov-Dec;81(6):406-9. doi: 10.1080/000155501317208336. Acta Derm Venereol. 2001. PMID: 11859942
-
Heterogeneous production of proteases from Brazilian clinical isolates of Pseudomonas aeruginosa.Enferm Infecc Microbiol Clin. 2017 Dec;35(10):630-637. doi: 10.1016/j.eimc.2016.06.015. Enferm Infecc Microbiol Clin. 2017. PMID: 27480954 English, Spanish.
-
Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.Curr Eye Res. 2007 Apr;32(4):373-86. doi: 10.1080/02713680701244181. Curr Eye Res. 2007. PMID: 17453960
-
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.Expert Rev Anti Infect Ther. 2015 May;13(5):605-13. doi: 10.1586/14787210.2015.1023291. Epub 2015 Mar 8. Expert Rev Anti Infect Ther. 2015. PMID: 25746414 Review.
-
A rapid molecular method for characterising bacterial bioburden in chronic wounds.J Wound Care. 2008 Dec;17(12):513-6. doi: 10.12968/jowc.2008.17.12.31769. J Wound Care. 2008. PMID: 19052515 Review.
Cited by
-
Molecular Mechanisms Involved in Pseudomonas aeruginosa Bacteremia.Adv Exp Med Biol. 2022;1386:325-345. doi: 10.1007/978-3-031-08491-1_12. Adv Exp Med Biol. 2022. PMID: 36258078 Review.
-
Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin.Antimicrob Agents Chemother. 2005 Aug;49(8):3281-8. doi: 10.1128/AAC.49.8.3281-3288.2005. Antimicrob Agents Chemother. 2005. PMID: 16048937 Free PMC article.
-
Pseudomonas aeruginosa virulence proteins pseudolysin and protease IV impede cutaneous wound healing.Lab Invest. 2020 Dec;100(12):1532-1550. doi: 10.1038/s41374-020-00478-1. Epub 2020 Aug 15. Lab Invest. 2020. PMID: 32801335 Free PMC article.
-
Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5.Infect Immun. 2010 Aug;78(8):3585-94. doi: 10.1128/IAI.01353-09. Epub 2010 May 24. Infect Immun. 2010. PMID: 20498262 Free PMC article.
-
Peptidomic analysis of endogenous and bacterial protease activity in human plasma and wound fluids.iScience. 2024 Jan 26;27(2):109005. doi: 10.1016/j.isci.2024.109005. eCollection 2024 Feb 16. iScience. 2024. PMID: 38333691 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous